Induced pluripotent stem cells (iPSCs) have become a major focus of scientific research, with over 33,000 publications on the topic currently available on PubMed.gov, the world’s leading database for scientific literature. These cells, which are reprogrammed from differentiated somatic cells back to an embryonic-like state, have opened up new possibilities in regenerative medicine, drug development, and disease modeling. Since the groundbreaking discovery of iPSCs in 2006, the field has seen rapid expansion, with an increasing number of research products and technologies entering the market. To fully understand the competitive landscape of iPSC-based innovations, it is crucial to explore the growing presence of competitors and the advancements made in this dynamic space. [Read more…]